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V
ertebrate animals possess multiple
anti-pathogen defenses. Individual
mechanisms usually are differentiated
into those that are immunologically adap-
tive vs. more “primitive” anti-pathogen
phenomena described as innate respon-
ses. Here I frame defenses used by
bacteria against bacteriophages as analog-
ous to these animal immune functions.
Included are numerous anti-phage defen-
ses in addition to the adaptive immunity
associated with CRISPR/cas systems. As
these other anti-pathogen mechanisms
are non-adaptive they can be described
as making up an innate bacterial immun-
ity. This exercise was undertaken in light
of the recent excitement over the discov-
ery that CRISPR/cas systems can serve, as
noted, as a form of bacterial adaptive
immunity. The broader goal, however, is
to gain novel insight into bacterial
defenses against phages by fitting these
mechanisms into considerations of how
multicellular organisms also defend them-
selves against pathogens. This comment-
ary can be viewed in addition as a bid
toward integrating these numerous bac-
terial anti-phage defenses into a more
unified immunology.
Nathan
1 suggests that we can “view immu-
nology as the host’s participation in the
competition between genomes” (p. 173).
With bacteria these competing genomes
include those associated with bacterio-
phages as well as the semi-autonomous
DNA of plasmids. In this commentary I
consider parallels between mechanisms of
phage resistance displayed by bacteria
2,3
and pathogen resistance provided by
animal immune systems. The larger goal,
toward which this commentary represents
only a beginning, is a better integration
of considerations of bacterial defenses
against phages with study of the myriad
defenses all species possess against micro-
bial antagonists. It should be noted in
addition that phages, like pathogens in
general, possess numerous mechanisms by
which they resist or otherwise overcome
these defenses. Nonetheless, for the sake
of concentrating on the bacterial rather
than the phage perspective in this com-
mentary, these phage counter-strategies
will not be addressed.
Traditionally, as well as didactically,
animal immune-system components have
been distinguished into those that are
adaptive—a.k.a., specific, acquired, or
anticipatory—and those that are not.
The latter, also described as innate,
4 are
both more evolutionarily primitive than
adaptive functions and are the predom-
inant immunity of invertebrate animals as
well as of plants.
5-7 This non-adaptive
immunity, often serving even for verte-
brate animals as a “first line of host
defense,”
8 includes a variety of mechan-
isms that do not change in their specificity
over the course of the expressing organ-
ism’s lifespan, except in terms of changes
in gene expression, cell proliferation (or
loss), or as a consequence of organism
maturation. Innate immunity, in other
words, consists of “hard-wired responses”
that change in their specificity only as
a consequence of undirected germ-line
modification.
9 Such relatively fixed pro-
tective functions can be of greater utility if
they recognize patterns associated with a
diversity of potential invaders, that is, if
they are relatively non-specific.
4
Immune functions can be further dif-
ferentiated into mechanisms that act extra-
cellularly, including at the level of cell
membranes, or alternatively intracellularly.
Examples of the former include general
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blocks that exist on pathogen penetration
into bodies including the barriers asso-
ciated with mucous or the acidity of gastric
juices, i.e., “anatomic and physiologic
barriers” (p. S24).
4 An additional aspect
of innate immunity is detection of injury,
4
a phenomenon also associated with bac-
teria including in the form of what is
known as a phage shock response, which





Resistance to pathogens also can result
from an absence of factors necessary for
pathogens to carry out their life cycles.
This can be an absence of surface receptors
necessary for viral adsorption or instead
difficulty interacting with intracellular
molecules that differ among potential host
organisms, molecules that can be func-
tionally but not necessarily structurally
equivalent. For example, this can be in
terms of phage modification of the pro-
moter specificity of a bacterium’s RNA
polymerase. More strictly defined, how-
ever, innate immunity involves the recog-
nition of general patterns seen among
pathogens but not self. This perception
is effected by fixed-specificity pattern
recognition receptors along with functions
that serve to disrupt invading pathogens
once they have been recognized. Toll-
like receptors in animals,
4,12 for exam-
ple, recognize patterns associated with
would-be pathogens, such as their lipo-
polysaccharide or the flagellin making





receptors which detect various pathogen
patterns such as flagellin as well as
mediating the adjuvant activity of alum—
instead act intracellularly.
4,9 Analogs to
these mechanisms, as listed in Table 1
and as I discuss below, exist in bacteria as
phage defenses. Indeed, as Raivio notes
(p. 557),
14 “‘innate’ mechanisms of
immunity against foreign DNA have long
been known (i.e., restriction-modification
systems, disguise or alteration of bacterio-
phage receptors on the cell surface).”
Resistance to pathogens also can stem
from a lack of specific factors required for
pathogen infection, and such mechanisms
can contribute to racial or species resist-
ance, which also can be described as a
racial or species immunity.
11 The most
common anti-phage defenses by bacteria
similarly do not involve a binding of
phage-produced molecules by bacteria-
produced molecules. These defenses
therefore are not pattern recognizing as
considered in the previous paragraph.
Such phage resistance includes, in parti-
cular, deficiencies in those molecules
that otherwise can be found on bacter-
ial surfaces—such as outer membrane
proteins or various motifs associated with
lipopolysaccharide—to which phages
bind in the course of adsorption, i.e., as
discussed in Hyman and Abedon
2 as well
as Labrie et al.
3 The result, in absence of
these receptor molecules, is an adsorption
resistance by bacteria to phages.
Such envelope-level receptors, as well as
various intracellularly located host mole-
cules—such as the NusA protein, the
E. coli version of which but not the
Salmonella version facilitates antitermina-
tion in phage l
15—are primary determi-
nants of phage host range.
2 In addition,
even bacteria that otherwise are suscepti-
ble to a given phage often can mutate to
phage resistance by either modifying or
eliminating phage-required bacterial fac-
tors such as surface receptors.
2,3 Organisms
in general are similarly innately resistant to
most pathogens because of specialization
by the latter to the unique molecules
associated with specific hosts.
16 The result
is a relative narrowness particularly of
phage host ranges that occurs seemingly
even in the absence of active bacterial
anti-phage defenses.
2
Like multicellular organisms, bacteria
also can display the equivalent of anatom-
ical and physiological barriers to pathogen
penetration (encounter blocks) such as
extracellular polymeric substances, includ-
ing capsules. These barriers may be
effective, however, only against those
Table1. Bacterial phage-resistance mechanisms and their animal-immune system analogs
Bacterial mechanism Description* Immune system analog
Encounter blocks Extracellular polymeric substances blocking virion
approach to bacterial surfaces, e.g., capsules
Anatomical or physiological barriers,
e.g., keratinized skin, mucous, etc.
Adsorption resistance
(envelope-level resistance)
Absence of necessary receptor molecules on bacterial
surfaces, resulting in binding failure
Racial or species immunity
Penetration blocks (exclusion;
superinfection exclusion)
Blocks on phage movement while in association with
host, in this case preventing entrance into host cytoplasm
during adsorption
Barrier responses to wounding (e.g., clotting);
localization of inflammatory responses
Immunity to superinfection
(homoimmunity)
Recognition of specific phage-associated motifs resulting
in blocks on phage replication
Lectin and alternative complement pathways;
response to recognition by toll-like receptors
Abortive infection Killing of phages but at cost of death of individual,
phage-exposed bacteria
Apoptosis induced via cell-mediated immunity;
action of interferon
Restriction-modification Generic features of organisms are targeted (recognition
sequences found in DNA); equivalent host features are
protected
Complement, especially alternative pathway;
recognition by natural killer cells of absence of class I
MHC; recognition of absence of CpG motif methylation
Phage growth limitation system Tagging of phages for elimination by clonally related cells Opsonization
CRISPR Phage resistance via acquisition of novel-to-host DNA
sequence
Adaptive immunity
*See Hyman and Abedon
2 and Labrie et al.
3 for review.
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pathogens that do not possess barrier-
surmounting adaptations, such as the
capsule-degrading depolymerase enzymes
produced by some phages.
2,3,17 The exist-
ence of these phage enzymes potentially
gives rise to a frequency-dependent selec-
tion for rare bacterial adsorption defenses,
which in turn may serve as an at least
partial explanation for why the chemical
structure of bacterial capsules can be
highly diverse.
18
Pattern recognition, by contrast,
involves binding of disruptive self mole-
cules to non-self molecular targets. To be
effective, a similarly destructive targeting
of self-molecules must be prevented.
Strategies for reducing self-targeting come
in numerous forms. One means involves
a differential masking of patterns that
otherwise are associated with both self
and non-self. An example of this strategy,
as associated with animals, is seen with the
alternative complement pathway: Com-
plement factor C3b can bind to both self
and non-self surfaces, potentially initiat-
ing destructive cascades, but the binding
is actively disrupted by self tissues. The
result is a “reverse recognition” of non-self
patterns, “It detects markers on host
cells and activates on anything that lacks
similar markers” (p. 116).
7 Alternatively,
natural killer cells target in part an absence
of class I major histocompatibility com-
plex (MHC) molecules, which can be
downregulated in tumors as well as by
cells infected by certain viruses. Such
downregulation occurs for the sake of
evading cytotoxic T lymphocytes which,
contrasting natural killer cells, target cells
that display MHC class I. The result is
natural killer cell “recognition of absence
of self,”
19 so-called “missing self.”
4 Micro-
bial DNA also can be recognized by
animals due to an absence of methyla-
tion of ‘CpG motifs’ (or ‘CpG oligo-
deoxynucleotides’,
20 that take the form
of RRCGYY). These motifs otherwise
(p. 123) “are underrepresented in mam-
malian DNA.”
21 MHC class I, and CpG
motif methylation as well as complement-
disrupting molecules, in other words, can
be viewed as self-indicating molecular
“tags.”
In bacteria a comparable differential-
masking function is provided by the com-
mon and diverse restriction-modification
systems: Recognizable patterns, called
restriction enzyme recognition sequences,
are found in both host and non-host
DNA, such as the palindromic GAATTC
of the restriction enzyme, EcoRI. Only
non-host DNA is targeted for cleavage
however, due to an absence of host
factors on that DNA, which are methyl
groups supplied by modification enzymes.
Indeed, flipping the idea of restriction-
modification being driven primarily by
the existence of recognition sequences,
which of course provides the utility of
restriction endonucleases to genetic engin-
eering, it is possible to view this use of
recognition sequences instead as a means
of limiting the number of targets that
must be tagged as self by modification
enzymes, i.e., just as presumably is the
case for CpG motif methylation descri-
bed above. In particular, all potential self
targets of these systems require self
modification to keep them from being
recognized as “missing self.” Too many
potential targets, as would occur given
too-short recognition sequences (e.g., two
nucleotides long), thus could be both
metabolically costly and risky in terms
of self being inadvertently left untagged.
Alternatively, too few potential targets,
resulting from too-long recognition se-
quences (e.g., ten nucleotides long), can
increase the likelihood that foreign DNA
will be inadvertently modified prior to
its restriction or otherwise evade recog-
nition altogether.
22,23 Correctly balanced,
restriction-modification thus can serve as
a relatively metabolically inexpensive gen-
eral killing mechanism, one that is capable
of recognizing patterns potentially asso-
ciated with a great diversity of targets but
which nonetheless is mostly limited in its
action to targeting non-self DNA.
Complement factors in animals as well
as antibodies can tag pathogens or sub-
stances for subsequent elimination, as
mediated ultimately via innate immune
functions such as phagocytosis. Analogous
tagging of phages for subsequent destruc-
tion seems to occur in conjunction with
the phage growth limitation systems of
Streptomyces coelicolor.
24 Here, phage infec-
tion of one cell results in phages that can
be destroyed by clonally related bacteria.
In particular, a phage burst is allowed
by the first infection but not upon
subsequent phage infection of related cells.
Unrelated cells, ones not carrying the
equivalent growth limitation system, by
contrast can support productive phage
infections by these same ‘second round’
phages. The mechanism by which sub-
sequent phage infections are blocked by
the phage growth limitation system may
be viewed as a bacterial equivalent to
opsonization,
12 i.e., the marking of organ-
isms and materials for elimination from
the body environment. This phage growth
limitation system thus requires at least
two cells to function, the tagging cell
which ultimately dies and the second cell
which inactivates the resulting phages
and ultimately lives.
More generally, bacterial abortive infec-
tion systems—which can be likened to the
apoptosis seen in multicellular organ-
isms
25—require more than one cell to be
ecologically useful. The first cell expresses
the anti-phage defense but then dies
either explicitly because of that defense
or instead because phage functions were
not blocked early enough to save the cell.
The mechanism may be evolutionarily
selected, however, only if a second or
more cell, also carrying the abortive
infection system allele or alleles, then
benefit from the sacrifice of the first
cell.
2,3 Cellular sacrifice more generally is
common in the functioning of animal
immunity, such as is seen with the short
life spans of neutrophilic leukocytes
26
or the natural killer- and cytotoxic T
lymphocyte-mediated elimination of virus-
infected as well as cancerous cells from
bodies.
Specific immunity is a characteristic
particularly of vertebrate animals and can
be described as “induced, highly specific,
anticipatory and clonal,” which contrasts
with the “nonanticipatory, nonclonal and
less specific” nature of innate immunity
(p. 13).
27 “Induced” refers to how specific
immunity develops and changes over the
course of an animal’s life span. “Anti-
cipatory” means an ability to recognize
more patterns than an organism’s lineage
is likely to ever see, “…enough receptors
in store to cover the entire universe of
epitopes, so that for every conceivable
epitope there is at least one correspond-
ing receptor” (p. 499).
28 The term “clo-
nal,” in turn, refers to a subtle genotypic
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diversification, within clonally derived
multicellular bodies, of this excess pattern-
recognition capacity. Indeed, specific
immunity involves a modification of the
genetic endowment of a multi-celled
entity’s immunological ensemble. “Highly
specific” describes the potential for adaptive
immunity to generate immune responses
that are tailored to relatively unique non-
self targets. This is rather than the more
broadly acting, “less specific” mechanisms
that are associated with non-specific, that
is, innate immunity.
For bacteria, such “highly specific”
immunity is exemplified by CRISPR/cas
systems.
2,3 Their functioning—where
CRISPR stands for Clustered Regularly
InterSpaced Short Palindromic Repeats—
also involves a modification of the genetic
endowment of an organism, a process
known as adaptation. This adaptation is
the product of a molecular mechanism
that effects the acquisition of what are
known as spacer sequences, DNA se-
quence that corresponds to proto-spacer
sequences associated with parasitic DNA.
Mechanisms that serve to deliver this
foreign DNA to CRISPR loci may be
viewed as analogous in their action to
antigen presentation in animals, which
contributes to the development of adap-
tive immunity by making degraded but
still potentially recognizable motifs avail-
able to helper T lymphocytes. Thus, just
as antigen-presenting cells can deliver
antigens in the context of MHC proteins
to T lymphocytes,
12 so too might various
mechanisms provide phage DNA to
CRISPR systems. This delivery associated
with CRISPR adaptation, though, occurs
intracellularly vs. the intercellular antigen
presentation seen in animals. Note that
prior to this DNA presentation, the phage-
infected bacterium must survive, and that
survival in at least some instances could
be due to the action of bacterial innate
phage-resistance functions, though alter-
natively could instead be associated with
phage infections that for various reasons
are not metabolically active.
29
Additional, though more general paral-
lels between bacterial and animal immun-
ity also exist. Immunological layering, for
example, is seen in multicellular organ-
isms: “Each phylogenetically new defense
mechanism does not replace an evolution-
ary older one, but supplements it, result-
ing in a layered structure” (p. 18).
27 The
resulting multiple resistance mechanisms
mean that fewer pathogens may be able to
evade immune system detection. So too,
and presumably for the similar reasons,
individual bacteria can possess multiple
phage-resistance mechanisms
3 that poten-
tially complement each other. The result-
ing layering of anti-phage resistance
mechanisms can include extracellular
blocks, envelope-level resistance mechan-
isms, various intracellular blocks on both
phage infection and phage-mediated kill-
ing of bacteria (restriction-modification
and CRISPR/Cas systems), and, lastly,
abortive infection mechanisms. Included
among this layering of multiple resist-
ance mechanisms is a redundant display
of similar resistance mechanisms such
as the encoding of several restriction-
modification systems
22 or instead multiple
loci of CRISPR arrays per bacterial
genome.
30 These together may serve to
increase the likelihood that a bacterial
lineage survives phage exposure.
Bacterial mechanisms of phage resist-
ance tend to be individually fallible, either
with otherwise sensitive phages occasion-
ally bypassing specific functions, such as
restriction-modification or abortive infec-
tion systems, or instead with phages
evading bacterial defenses via “escape” or
host-range mutations. Abortive infection
systems, because they do not protect
the viability of individual bacteria even
when functioning properly, in fact inher-
ently leave bacteria susceptible to phage-
mediated killing. The result is that
bacterial populations, in spite of phage
resistance mechanisms, often can be over-
whelmed given exposure especially to
large numbers of phages. This might be
viewed equivalently to how most animal
pathogens have associated infectious
doses, with exposure to lower than
infectious doses leading to control by
innate immune mechanisms while larger
doses potentially overwhelm these same
systems.
Only those bacteria that have mutated
to phage resistance may survive exposure
to phages to which their parent popula-
tion would be sensitive. Mutations, such
as to genes specifying surface molecules,
often result in bacterial loss of function,
however.
2 For those bacteria possessing
CRISPR/cas systems, and therefore adapt-
ive immunity, survival instead may be
achieved without such mutational loss.
Indeed, an important utility of adaptive
immunity, in vertebrate animals, is the
achievement of a pathogen-mitigating
genetic diversification that is highly tar-
geted within the expressing organism’s
genome. Achieving resistance to pathogens
through targeted genomic modification
presumably is less costly, on average, than
resistance that stems instead from genome-
wide random mutation.
The parallels between bacteria and
multicellular organisms go further than
just in terms of their collective need to
resist pathogens as competing genomes.
Bacteria, in particular, also can exist in
a quasi multicellular forms, i.e., as bio-
films.
17 These biofilms and their con-
stituent microcolonies, like multicellular
organisms, however can constitute larger
target sizes for acquisition by parasitic
or pathogenic organisms. Resulting
infections also can give rise to situations
where exploitation in one location can
lead to exploitation in other locations
of the same collection of clonally related
cells, such as focal infections in animals
or, for bacteria, phage penetration into
biofilms or microcolonies.
17 It is likely
that for clonal organisms to take up
multicellular or colonial lifestyles, given
this perhaps inherent potential for
increased vulnerability to existing patho-
gens, they must first display greater
levels of resistance or immunity than
can be required for the success of
smaller as well as more-dispersed single-
celled organisms. Bacterial microcolonies
thus might serve as models for the study
of evolutionary transitions from a uni-
cellular to more colonial or multicellular
existence, including in terms of the deve-
lopment of strategies of anti-pathogen
immunity.
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